Rutledge Cancer Foundation Honors Dr. Anna Nackley of CARE Fertility with the "Heart of Gold" Award for Fertility Preservation Services for Cancer Patients

Monday, October 8, 2018 Cancer News
Email Print This Page Comment bookmark
Font : A-A+

Leader in assisted reproductive technology offers support for patients undergoing cancer treatment

DALLAS, Oct. 08, 2018 /PRNewswire-PRWeb/ -- The Center for Assisted Reproduction, CARE Fertility, today announces

the center was recognized by Rutledge Cancer Foundation with the "Heart of Gold" Award for providing fertility preservation services to young adult patients undergoing cancer treatment. The award was presented to CARE Fertility's Anna Chan Nackley, M.D. during the Hearts of Gold Luncheon hosted by the Rutledge Cancer Foundation.

The Rutledge Cancer Foundation hosts the Hearts of Gold Luncheon with a goal of raising awareness and support to care for adolescent and young adult cancer patients. The foundation is committed to finding less toxic and more curative treatment for sarcoma and other solid tumor cancers. Celebrating eight years, donations made during the luncheon help fund research and clinical trials, programs and outreach for adolescent and young adult cancer patients, and grants for fertility preservation cycles.

"It was an honor for me to be the recipient of the Heart of Gold award and for my team at CARE Fertility to be recognized for providing fertility preservation services to the community," says Dr. Nackley. "We understand the time-sensitivity and the vulnerability of these young women and do our best to provide prompt and personalized support by fast-tracking their treatment cycles and assisting them in obtaining all their medicines. We have a team approach and work closely with the referring oncologists assuring availability year-round. We want to help these young women understand how cancer and cancer treatments affect fertility, and to let them know that our goal is to give them hope for the future. We are grateful to the Rutledge Cancer Foundation for their continued support."

CARE Fertility offers newly-diagnosed cancer patients rapid consultation regarding treatment options for fertility preservation prior to undergoing surgery, radiation or chemotherapy, which can result in future infertility. Fertility preservation options, such as egg and embryo freezing are available at special rates for patients undergoing cancer treatment. CARE Fertility doctors and staff work in collaboration with the patients' oncologists and surgeons to determine the best treatment options. To schedule a consultation, call 817-540-1157.

Laura Rutledge, executive director of Rutledge Cancer Foundation, adds, "With the support and commitment of Moncrief Cancer Institute and dedicated reproductive oncologists like Dr. Nackley, the Rutledge Cancer Foundation has been able to create and support a community-driven program whereby every young person diagnosed with cancer in the Fort Worth area should have access to counseling and procedures to preserve their fertility before beginning their cancer treatment. We hope to help other communities learn how to replicate this collaborative Fertility Preservation Program that brings hope to an otherwise challenging and uncertain time."

To learn more and to donate to the Rutledge Cancer Foundation, visit RutledgeCancerFoudation.org.

About Center for Assisted Reproduction The Center for Assisted Reproduction (CARE Fertility) is a pioneer in assisted reproductive technologies in the north Texas region with several firsts including the first ICSI pregnancies and the first to successfully implement a blastocyst culture system. With two state-of-the-art facilities in Bedford, TX and Fort Worth, TX, CARE Fertility offers the full gamut of fertility and assisted reproductive technology treatments. CARE Fertility is the most experienced practice offering effortless IVF, and the first in the world to use the InvoCell device blastocyst, Day 5 Embryo transfer. CARE Fertility can offer effortless IVF at half the cost of traditional IVF due to lower dose of medications and minimal monitoring — all while maintaining high success rates. Learn more at Embryo.net, on Facebook, Twitter and Instagram @CAREFertilityUS.

 

SOURCE Center for Assisted Reproduction



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store